Orion Oyj Stock price

Equities

ORNBV

FI0009014377

Pharmaceuticals

Market Closed - Nasdaq Helsinki 11:29:51 2023-12-07 am EST Intraday chart for Orion Oyj 5-day change 1st Jan Change
36.24 EUR +0.36% -0.55% -29.27%
Sales 2023 * 1.18B 1.28B Sales 2024 * 1.29B 1.39B Capitalization 5.08B 5.48B
Net income 2023 * 191M 206M Net income 2024 * 237M 256M EV / Sales 2023 *
4,23x
Net cash position 2023 * 66.86M 72.14M Net cash position 2024 * 106M 114M EV / Sales 2024 *
3,86x
P/E ratio 2023 *
26,7x
P/E ratio 2024 *
21,5x
Employees 3,574
Yield 2023 *
4,46%
Yield 2024 *
4,64%
Free-Float 88.69%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.36%
1 week-0.71%
Current month-0.55%
1 month-1.66%
3 months-3.31%
6 months-9.99%
Current year-29.27%
More quotes
1 week
35.84
Extreme 35.84
36.92
1 month
35.84
Extreme 35.84
38.06
Current year
32.89
Extreme 32.89
55.16
1 year
32.89
Extreme 32.89
55.16
3 years
32.51
Extreme 32.51
55.16
5 years
28.19
Extreme 28.19
55.16
10 years
18.61
Extreme 18.61
58.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 1998
Director of Finance/CFO 62 2000
Chief Tech/Sci/R&D Officer 61 2020
Members of the board TitleAgeSince
Chairman 67 2014
Director/Board Member 62 2021
Director/Board Member 60 2017
More insiders
Date Price Change Volume
23-12-07 36.24 +0.36% 222,676
23-12-05 36.11 -0.74% 256,087
23-12-04 36.38 -0.30% 139,525
23-12-01 36.49 +0.14% 164,972
23-11-30 36.44 -0.16% 832,259

Delayed Quote Nasdaq Helsinki, December 07, 2023 at 11:29 am EST

More quotes
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - generic, OTC and biosimilar drugs (48.3%); - patented prescription products (37.3%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - pharmaceutical ingredients and outsourcing services (7.2%) ; - animal products (7%); - other (0.2%). Net sales are distributed geographically as follows: Finland (30.3%), Scandinavia (13.6%), Europe (34%), North America (8.6%) and other (13.5%).
Calendar
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
36.24EUR
Average target price
42.52EUR
Spread / Average Target
+17.32%
Consensus
1st Jan change Capi.
-29.27% 5 468 M $
+60.80% 530 B $
+42.05% 438 B $
-12.03% 377 B $
-6.37% 268 B $
-8.44% 258 B $
-14.13% 230 B $
+0.79% 200 B $
-9.98% 198 B $
-44.13% 163 B $
Other Pharmaceuticals
  1. Stock
  2. Equities
  3. Stock Orion Oyj - Nasdaq Helsinki
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer